The program aims to accelerate the development of 6 Indian innovations to improve ease of access to diagnostics and treatment monitoring
India has been declared ‘functional’ against all the core regulatory functions of the WHO Global Benchmarking Tool Version VI
The partnership marks a pivotal step towards developing new therapies for combating Sickle Cell Disease
WHO estimates suggest that 150 million people worldwide are affected by Trachoma
The Lilly Medicine Foundry is set to drive innovation in drug production and make medicines for clinical trials
Potential of Ayurveda’s contribution in global health system through various innovative practices
India has taken the lead in recognising NAFLD as a major non-communicable disease
Quinidine Sulphate helps manage rare irregular heartbeat conditions
NMC to continue its efforts to improve and enhance the quality of medical education in the country
India's bio economy has experienced remarkable growth, skyrocketing from US $10 billion in 2014 to over $130 billion in 2024, with projections to reach $300 billion by 2030
Subscribe To Our Newsletter & Stay Updated
